<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">106119</article-id><article-id pub-id-type="doi">10.7554/eLife.106119</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Neurodegeneration</subject></subj-group></article-categories><title-group><article-title>A role for RNA knots in Alzheimer’s disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Galli</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Silvia Galli</bold> is at Imperial College London, London, United Kingdom</p></bio></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Di Antonio</surname><given-names>Marco</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7321-1867</contrib-id><email>m.di-antonio@imperial.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Marco Di Antonio</bold> is at Imperial College London, London, United Kingdom</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041kmwe10</institution-id><institution>Imperial College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>28</day><month>02</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e106119</elocation-id><permissions><copyright-statement>© 2025, Galli and Di Antonio</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Galli and Di Antonio</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-106119-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.105446" id="ra1"/><abstract><p>The buildup of knot-like RNA structures in brain cells may be the key to understanding how uncontrolled protein aggregation drives Alzheimer’s disease.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>G-quadruplex</kwd><kwd>alzheimer's disease</kwd><kwd>aging</kwd><kwd>RNA</kwd><kwd>tau</kwd><kwd>APOE</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The buildup of knot-like RNA structures in brain cells may be the key to understanding how uncontrolled protein aggregation drives Alzheimer’s disease.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Kallweit L, Hamlett ED, Saternos H, Gilmore A, Granholm AC, Horowitz S. 2025. Chronic RNA G-quadruplex accumulation in aging and Alzheimer’s disease. <italic>eLife</italic> <bold>14</bold>:RP105446. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.105446">10.7554/eLife.105446</ext-link>.</p></boxed-text><p>Memories are fundamental to any human being. They provide a sense of self-identity and shape our perception of the world and our loved ones. This is why neurogenerative diseases involving memory loss, like dementia, are highly debilitating, even when an individual’s physical fitness is not affected.</p><p>Alzheimer’s disease is the most common type of dementia, accounting for 60–70% of all cases, and it is projected that around 139 million will be suffering from the disease by 2050 (<xref ref-type="bibr" rid="bib8">WHO, 2023</xref>). This means that a significant proportion of the world’s population will lose their precious memories in the foreseeable future, resulting in unsustainable pressure on the healthcare system. Given the lack of viable therapies currently available to treat Alzheimer’s, there is an urgent need to identify new molecular targets that can be leveraged to develop innovative therapeutic agents.</p><p>Although the exact mechanisms that lead to Alzheimer’s disease are not fully understood, it is well known that an uncontrolled build-up of insoluble protein aggregates in the brain is a hallmark of the disease. Amyloid-beta proteins have been shown to accumulate as clumps outside brain cells, whilst p-tau proteins clump to form neurofibrillary tangles that have been detected in the cytoplasm of neurons and other brain cells (<xref ref-type="bibr" rid="bib2">Braak and Braak, 1995</xref>; <xref ref-type="bibr" rid="bib4">Furman et al., 2017</xref>).</p><p>In this context, RNA molecules that stabilize protein aggregates are becoming increasingly relevant as potential therapeutic targets (<xref ref-type="bibr" rid="bib6">Raguseo et al., 2023</xref>; <xref ref-type="bibr" rid="bib9">Wolozin and Apicco, 2015</xref>). Recently, RNA structures called G-quadruplexes – known for their roles in gene expression and protein production – have emerged as key drivers of aggregate formation in brain cells affected by amyotrophic lateral sclerosis, raising the possibility that they may also be implicated in other neurodegenerative diseases, such as Alzheimer’s disease (<xref ref-type="bibr" rid="bib6">Raguseo et al., 2023</xref>). Now, in eLife, Scott Horowitz and colleagues from the University of Denver, the Medical University of South Carolina, and the University of Colorado – including Lena Kallweit as first author – report that brain samples taken from Alzheimer’s disease patients show a significant accumulation of RNA G-quadruplex structures (<xref ref-type="bibr" rid="bib5">Kallweit et al., 2025</xref>).</p><p>Kallweit et al. studied brain tissues from deceased people with Alzheimer’s disease aged between 30 and 92 years. Using a combination of immunostaining and fluorescence microscopy, the team showed that older patients had a higher number of RNA G-quadruplexes than younger patients. This connection became even stronger as the disease progressed. The prevalence of RNA G-quadruplexes further increased with the size of the area where p-tau aggregates accumulated.</p><p>Besides aging, genetic factors can also contribute to the development of Alzheimer’s disease. It is known that a specific variant of the gene APOE (known as APOE4) is linked to the accumulation of amyloid-beta aggregates (<xref ref-type="bibr" rid="bib3">Cicognola et al., 2025</xref>). Taking this into account, Kallweit et al. showed that brain samples from patients with the APOE4 variant had a higher number of RNA G-quadruplexes than those without the variant. This suggests that genetic variations known to promote the accumulation of protein aggregates linked to Alzheimer’s disease could also potentially drive the accumulation of RNA G-quadruplex structures.</p><p>Taken together, the findings suggest that RNA G-quadruplexes may have an active role in neurodegeneration and support a model in which RNA G-quadruplexes could become tangled with p-tau proteins, leading to insoluble aggregates inside brain cells (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This idea is further supported by previous research showing that RNA G-quadruplexes increase the aggregation of p-tau in experiments with cultured cells (<xref ref-type="bibr" rid="bib10">Zwierzchowski-Zarate et al., 2022</xref>). This suggests that accumulating RNA G-quadruplexes in brain cells, especially when combined with genetic variations such as APOE4 and aging, may promote the formation of p-tau aggregates that drive Alzheimer’s disease.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The role of RNA G-quadruplexes in Alzheimer’s Disease.</title><p>Kallweit et al. analyzed brain cells taken from deceased patients with Alzheimer’s disease. This revealed that RNA structures called RNA G-quadruplexes (red structures, left), which help regulate gene expression, accumulate in the same location as p-tau protein clusters (green, right). Clumps of protein p-tau and RNA G-quadruplexes overlapped in brain cells (blue structure in the center). This figure was created using <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/j70d963">BioRender.com</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106119-fig1-v1.tif"/></fig><p>The results of Kallweit et al. further highlight the potential of targeting RNA – including G-quadruplexes – to diagnose or treat neurodegenerative diseases (<xref ref-type="bibr" rid="bib1">Abad-Yang et al., 2025</xref>). Given the high correlation with the severity of Alzheimer’s disease, RNA G-quadruplexes could be used as a biomarker for early Alzheimer’s disease development to help accelerate diagnoses. RNA targeting and degradation have been successfully employed in other conditions, which may one day be a reality for Alzheimer’s disease (<xref ref-type="bibr" rid="bib7">Tong et al., 2024</xref>). In the future, small molecules that can target and dissolve RNA complexes may be the key to treating incurable neurodegenerative conditions like Alzheimer’s.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abad-Yang</surname><given-names>N</given-names></name><name><surname>Raguseo</surname><given-names>F</given-names></name><name><surname>Di Michele</surname><given-names>L</given-names></name><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Di Antonio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>The potential of multimolecular G-quadruplex structures for targeted treatment of Amyotrophic Lateral Sclerosis</article-title><source>Expert Opinion on Therapeutic Targets</source><volume>1</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/14728222.2025.2463361</pub-id><pub-id pub-id-type="pmid">39902643</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Staging of Alzheimer’s disease-related neurofibrillary changes</article-title><source>Neurobiology of Aging</source><volume>16</volume><elocation-id>00030-I</elocation-id><pub-id pub-id-type="doi">10.1016/0197-4580(95)00030-I</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicognola</surname><given-names>C</given-names></name><name><surname>Salvadó</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Palmqvist</surname><given-names>S</given-names></name><name><surname>Stomrud</surname><given-names>E</given-names></name><name><surname>Betthauser</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Janelidze</surname><given-names>S</given-names></name><name><surname>Mattsson-Carlgren</surname><given-names>N</given-names></name><name><surname>Hansson</surname><given-names>O</given-names></name><name><surname>Binette</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta 2</article-title><source>Brain: A Journal of Neurology</source><volume>1</volume><elocation-id>awaf016</elocation-id><pub-id pub-id-type="doi">10.1093/brain/awaf016/7958226</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>JL</given-names></name><name><surname>Vaquer-Alicea</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>CL</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Nelson</surname><given-names>PT</given-names></name><name><surname>Diamond</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Widespread tau seeding activity at early Braak stages</article-title><source>Acta Neuropathologica</source><volume>133</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1007/s00401-016-1644-z</pub-id><pub-id pub-id-type="pmid">27878366</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallweit</surname><given-names>L</given-names></name><name><surname>Hamlett</surname><given-names>ED</given-names></name><name><surname>Saternos</surname><given-names>H</given-names></name><name><surname>Gilmore</surname><given-names>A</given-names></name><name><surname>Granholm</surname><given-names>AC</given-names></name><name><surname>Horowitz</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Chronic RNA G-quadruplex accumulation in aging and Alzheimer’s disease</article-title><source>eLife</source><volume>14</volume><elocation-id>RP105446</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.105446</pub-id><pub-id pub-id-type="pmid">39992714</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raguseo</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Petrić Howe</surname><given-names>M</given-names></name><name><surname>Balendra</surname><given-names>R</given-names></name><name><surname>Huyghebaert</surname><given-names>A</given-names></name><name><surname>Vadukul</surname><given-names>DM</given-names></name><name><surname>Tanase</surname><given-names>DA</given-names></name><name><surname>Maher</surname><given-names>TE</given-names></name><name><surname>Malouf</surname><given-names>L</given-names></name><name><surname>Rubio-Sánchez</surname><given-names>R</given-names></name><name><surname>Aprile</surname><given-names>FA</given-names></name><name><surname>Elani</surname><given-names>Y</given-names></name><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Di Michele</surname><given-names>L</given-names></name><name><surname>Di Antonio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>8272</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-43872-1</pub-id><pub-id pub-id-type="pmid">38092738</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Grudniewska</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>I</given-names></name><name><surname>Abegg</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Childs-Disney</surname><given-names>JL</given-names></name><name><surname>Gibaut</surname><given-names>QMR</given-names></name><name><surname>Haniff</surname><given-names>HS</given-names></name><name><surname>Adibekian</surname><given-names>A</given-names></name><name><surname>Mouradian</surname><given-names>MM</given-names></name><name><surname>Disney</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera</article-title><source>PNAS</source><volume>121</volume><elocation-id>e2306682120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2306682120</pub-id><pub-id pub-id-type="pmid">38181056</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2023">2023</year><article-title>Dementia</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/dementia">https://www.who.int/news-room/fact-sheets/detail/dementia</ext-link><date-in-citation iso-8601-date="2025-02-11">February 11, 2025</date-in-citation></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolozin</surname><given-names>B</given-names></name><name><surname>Apicco</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RNA binding proteins and the genesis of neurodegenerative diseases</article-title><source>Advances in Experimental Medicine and Biology</source><volume>822</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-08927-0_3</pub-id><pub-id pub-id-type="pmid">25416971</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwierzchowski-Zarate</surname><given-names>AN</given-names></name><name><surname>Mendoza-Oliva</surname><given-names>A</given-names></name><name><surname>Kashmer</surname><given-names>OM</given-names></name><name><surname>Collazo-Lopez</surname><given-names>JE</given-names></name><name><surname>White</surname><given-names>CL</given-names></name><name><surname>Diamond</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds</article-title><source>The Journal of Biological Chemistry</source><volume>298</volume><elocation-id>102132</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102132</pub-id><pub-id pub-id-type="pmid">35700826</pub-id></element-citation></ref></ref-list></back></article>